Hongjie Qian, Jie Cheng, Yuzhou Gui, Wei Wang, Liyu Liang, Huijuan Zhu, . . . Jingying Jia. (2023). A phase I study comparing the pharmacokinetics and safety of HS628 (tocilizumab biosimilar) and reference tocilizumab in healthy male subjects. Wiley.
Chicago Style (17th ed.) CitationHongjie Qian, et al. A Phase I Study Comparing the Pharmacokinetics and Safety of HS628 (tocilizumab Biosimilar) and Reference Tocilizumab in Healthy Male Subjects. Wiley, 2023.
MLA (9th ed.) CitationHongjie Qian, et al. A Phase I Study Comparing the Pharmacokinetics and Safety of HS628 (tocilizumab Biosimilar) and Reference Tocilizumab in Healthy Male Subjects. Wiley, 2023.
Warning: These citations may not always be 100% accurate.